---
figid: PMC5228544__ol-12-06-4305-g00
figtitle: Roles of TBX2 and TBX3 in tumorigenesis and tumor progression
organisms:
- Gallus gallus
- Danio rerio
- Xenopus laevis
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- clinical samples
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Gallus gallus
- Danio rerio
- Caenorhabditis elegans
- Xenopus laevis
pmcid: PMC5228544
filename: ol-12-06-4305-g00.jpg
figlink: /pmc/articles/PMC5228544/figure/f1-ol-0-0-5296/
number: F1
caption: 'Roles of TBX2 and TBX3 in tumorigenesis and tumor progression. Pointed arrowheads
  indicate activation; flat arrowheads indicate inhibition. Invasion and migration:
  B-RAF induces the expression of TBX3, which represses E-cadherin expression; AKT3
  promotes the expression of TBX3 and enhances the ability of TBX3 to repress expression
  of E-cadherin; PMA increases TBX3 mRNA and protein levels in a protein kinase C-dependent
  manner via AP-1. Anti-senescence and proliferation: Elevated TBX2 levels antagonize
  PML pro-senescence functions through direct protein-protein interactions; TBX2 co-represses
  NDRG1 through recruitment of EGR1; TBX2 knockdown causes a reduction in phosphorylated
  Chk2, p53 and p21CIP1 proteins levels; TBX2 and TBX3 inhibit p14ARF expression,
  which inhibits downstrean MDM2, p53 and p21CIP1 expression; TBX3 is a downstream
  target gene of the Wnt/β-catenin signaling pathway. Tumorigenesis: TBX2 may upregulate
  the expression of PSCA and PIWIL1; TBX3 interacts with HDAC1, 2, 3 and 5, and represses
  p14ARF expression; overexpression of TBX3 causes a reduction in PTEN mRNA and protein
  levels. EMT: Ectopic expression of TBX2 induces loss of epithelial adhesion, decreased
  expression of proteins involved in epithelial cell adhesion (E-cadherin, β-catenin,
  ZO1) and an abnormal gain of mesenchymal markers (N-cadherin, Vimentin). TBX, T-box;
  B-RAF, B-Raf proto-oncogene; AKT3, Akt serine/threonine kinase 3; PMA, phorbol-12-myristate-13-acetate;
  AP-1, activator protein 1; NDRG1, N-myc downregulated gene 1; EGR1, early growth
  response protein 1; CHK2, checkpoint kinase 2; PSCA, prostate stem cell antigen;
  PIWIL, piwi-like RNA-mediated gene silencing 1; HDAC, histone deacetylase; PTEN,
  phosphatase and tensin homolog; ZO1, zonula occludens-1; siRNA, small interfering
  RNA.'
papertitle: The role of T-box genes in the tumorigenesis and progression of cancer.
reftext: Fangyuan Chang, et al. Oncol Lett. 2016 Dec;12(6):4305-4311.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9227402
figid_alias: PMC5228544__F1
figtype: Figure
redirect_from: /figures/PMC5228544__F1
ndex: 2d591e16-dea0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5228544__ol-12-06-4305-g00.html
  '@type': Dataset
  description: 'Roles of TBX2 and TBX3 in tumorigenesis and tumor progression. Pointed
    arrowheads indicate activation; flat arrowheads indicate inhibition. Invasion
    and migration: B-RAF induces the expression of TBX3, which represses E-cadherin
    expression; AKT3 promotes the expression of TBX3 and enhances the ability of TBX3
    to repress expression of E-cadherin; PMA increases TBX3 mRNA and protein levels
    in a protein kinase C-dependent manner via AP-1. Anti-senescence and proliferation:
    Elevated TBX2 levels antagonize PML pro-senescence functions through direct protein-protein
    interactions; TBX2 co-represses NDRG1 through recruitment of EGR1; TBX2 knockdown
    causes a reduction in phosphorylated Chk2, p53 and p21CIP1 proteins levels; TBX2
    and TBX3 inhibit p14ARF expression, which inhibits downstrean MDM2, p53 and p21CIP1
    expression; TBX3 is a downstream target gene of the Wnt/β-catenin signaling pathway.
    Tumorigenesis: TBX2 may upregulate the expression of PSCA and PIWIL1; TBX3 interacts
    with HDAC1, 2, 3 and 5, and represses p14ARF expression; overexpression of TBX3
    causes a reduction in PTEN mRNA and protein levels. EMT: Ectopic expression of
    TBX2 induces loss of epithelial adhesion, decreased expression of proteins involved
    in epithelial cell adhesion (E-cadherin, β-catenin, ZO1) and an abnormal gain
    of mesenchymal markers (N-cadherin, Vimentin). TBX, T-box; B-RAF, B-Raf proto-oncogene;
    AKT3, Akt serine/threonine kinase 3; PMA, phorbol-12-myristate-13-acetate; AP-1,
    activator protein 1; NDRG1, N-myc downregulated gene 1; EGR1, early growth response
    protein 1; CHK2, checkpoint kinase 2; PSCA, prostate stem cell antigen; PIWIL,
    piwi-like RNA-mediated gene silencing 1; HDAC, histone deacetylase; PTEN, phosphatase
    and tensin homolog; ZO1, zonula occludens-1; siRNA, small interfering RNA.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Trp53
  - Ndrg1
  - Chek2
  - Mdm2
  - Pml
  - Fxyd1
  - Egr1
  - Ctnnb1
  - Psca
  - Piwil1
  - Tbx2
  - Tbx3
  - Pten
  - Jun
  - Akt3
  - Braf
  - Cdh1
  - Fzr1
  - Cdh2
  - pma
  - Itk
  - Slc22a3
  - TP53
  - TP63
  - TP73
  - NDRG1
  - CHEK2
  - MDM2
  - PML
  - EGR1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - CDKN2A
  - PSCA
  - PIWIL1
  - TBX2
  - TBX3
  - PTEN
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - AKT3
  - BRAF
  - CDH1
  - FZR1
  - CDH2
  - ITK
  - SLC22A3
  - OPN2SW
  - GPIHBP1
  - tp53
  - ndrg1a
  - mdm2
  - egr1
  - ctnnb1
  - piwil1
  - tbx2b
  - tbx3a
  - ptenb
  - akt3a
  - akt3b
  - braf
  - si:dkey-222f8.3
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - cdh2
  - chk-2
  - tbx-2
  - cdh-1
  - tp53.L
  - tp53.S
  - ndrg1.S
  - chek2.L
  - mdm2.S
  - egr1.L
  - egr1.S
  - ctnnb1.S
  - ctnnb1.L
  - tbx2.S
  - tbx2.L
  - tbx3.L
  - tbx3.S
  - jun.S
  - jun.L
  - braf.S
  - snrpe.S
  - snrpe.L
  - braf.L
  - cdh3.S
  - cdh3.L
  - cdh1.L
  - cdhn-b
  - cdh2.S
  - itk.L
  - Cancer
---
